Startups
On target is fine. On goal is everything.
OncoGenomX is a prediction software company known for its revolutionary approach to individualized drug-tumor matching, with the mission to end under- and overtreatment of patients, avoid unnecessary costs, and minimize the risk of failure and liability.
Our software (PredictionStar) enables prescription of more than 20 different anti-cancer drugs – biologically targeted, goal oriented, evidence-based, and applicable, for certainty of therapy success before starting treatment.
As the pioneers of biology-based drug-tumor matching and leader of reliable outcome prediction ahead of therapy start OncoGenomX is already a trusted name among breast cancer specialists. Working closely with oncologists, clinical researchers, international clinical study consortia and partner companies, OncogenomX is committed to game-changing software innovations - For optimal therapy of all tumors and all patients every time. For value-based cancer care, enabling longer, healthier, and better lives of people with cancer.
Do you want to be a part of an innovation that redefines clinical decision support?
We would love to hear from you and work together on creating an outcome and patient-oriented future.
OncoGenomX is a prediction software company known for its revolutionary approach to individualized drug-tumor matching, with the mission to end under- and overtreatment of patients, avoid unnecessary costs, and minimize the risk of failure and liability.
Our software (PredictionStar) enables prescription of more than 20 different anti-cancer drugs – biologically targeted, goal oriented, evidence-based, and applicable, for certainty of therapy success before starting treatment.
As the pioneers of biology-based drug-tumor matching and leader of reliable outcome prediction ahead of therapy start OncoGenomX is already a trusted name among breast cancer specialists. Working closely with oncologists, clinical researchers, international clinical study consortia and partner companies, OncogenomX is committed to game-changing software innovations - For optimal therapy of all tumors and all patients every time. For value-based cancer care, enabling longer, healthier, and better lives of people with cancer.
Do you want to be a part of an innovation that redefines clinical decision support?
We would love to hear from you and work together on creating an outcome and patient-oriented future.
Overview
Location
Switzerland, Basel-Landschaft, Allschwil
Employees
1-10
Founded date
2020
FAQ about OncoGenomX
When was OncoGenomX founded?
OncoGenomX was founded in 2020.
Is OncoGenomX still active?
Yes, OncoGenomX is active; its latest activity on Parsers VC dates from Aug 13, 2022.